STILL DISEASE
Clinical trials for STILL DISEASE explained in plain language.
Never miss a new study
Get alerted when new STILL DISEASE trials appear
Sign up with your email to follow new studies for STILL DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study tracks ilaris use in rare inflammatory diseases across europe
Disease control Recruiting nowThis study looks at how patients with Familial Mediterranean Fever (FMF) and Still's disease (including systemic juvenile idiopathic arthritis and adult-onset Still's disease) use the drug canakinumab (Ilaris) over the long term. Researchers will track 160 patients across Europe …
Matched conditions: STILL DISEASE
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 11, 2026 12:09 UTC
-
New study aims to unravel mysteries of rare inflammatory disease
Knowledge-focused Recruiting nowThis study will follow 500 adults and children with Still disease, a rare inflammatory condition causing fevers, joint pain, and rash. Researchers want to learn why the disease affects different age groups and why symptoms vary. The goal is to improve diagnosis, find better treat…
Matched conditions: STILL DISEASE
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:52 UTC
-
5,000 patients to help unlock secrets of inflammatory heart disease
Knowledge-focused Recruiting nowThis study aims to learn how well heart scans (MRI, ultrasound, PET) can detect and predict outcomes in people with suspected or known inflammatory heart diseases. Researchers will follow 5,000 adults for one year to see how often heart involvement is confirmed and how it affects…
Matched conditions: STILL DISEASE
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 12, 2026 12:06 UTC